These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 12262142)

  • 1. Hysterography and the IUD.
    Reiertsen O; Eyjolfsson O
    Contracept Deliv Syst; 1980 Oct; 1(4):389-98. PubMed ID: 12262142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Management of abnormal bleeding in an intrauterine device user].
    Desmons F; Adam-steen C
    Cah Sexol Clin; 1985; 11(63):185-7. PubMed ID: 12281357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical ('stress') evaluation of the combined ML Copper 250-short IUD in nulliparous women.
    Goldstuck ND
    Contracept Deliv Syst; 1981 Oct; 2(4):287-93. PubMed ID: 12336989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time ultrasonography for location of IUDs.
    Reiertsen O
    Contracept Deliv Syst; 1981 Apr; 2(2):163-9. PubMed ID: 12262543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrauterine devices (IUDs) and their complications (clinical evaluation of 2013 women with IUD in-situ).
    Ayhan A; Ozalp S; Aslan A
    Acta Reprod Turc; 1982 Oct; 4(2):34-8. PubMed ID: 12267258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intrauterine contraception in women over 35-years old: comparison between copper and progesterone IUDs].
    Calzolari E; Galoppi P; Masala L; Parisi C; Iannucci D; Salmaggi P; Custo GM; Zichella L
    Patol Clin Ostet Ginecol; 1985; 13(1):49-56. PubMed ID: 12342024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IUD failures--possible mechanisms.
    Barwin BN; Gillieson M
    Contracept Deliv Syst; 1983 Sep; 4(4):311-6. PubMed ID: 12265807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hysterographic study of some side effects of the copper T 200 device.
    Hefnawi FI; Hamed AF; Askalani H; Younis N; El Sheikha Z; Sherif H
    Popul Sci; 1982; (3):73-91. PubMed ID: 12266220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose concentration of cervical mucus in Copper T IUD users.
    Kandil O; Hassanein M; Zaki K; Rizk GA
    Contracept Deliv Syst; 1983 Jul; 4(3):195-201. PubMed ID: 12265362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Physical properties and PGE2 and PGF2 alpha content of cervical mucus in women wearing IUD compared to those not wearing IUD].
    Yao J; Zhou SW
    Shengzhi Yu Biyun; 1984 May; 4(2):51-3. PubMed ID: 12313204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avoidance of the dimensional incompatibility as the main reason for side effects in intrauterine contraception.
    Kurz KH
    Contracept Deliv Syst; 1981 Jan; 2(1):21-9. PubMed ID: 12278585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hysterography and menstrual blood loss in women using the T Cu 200 device.
    Hefnawi F; Hamed AF; Younis N; El-sheikha Z; Sherif H
    Contracept Deliv Syst; 1980 Jan; 1(1):63-70. PubMed ID: 12261719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hysteroscopic findings in complicated and non-complicated IUD users.
    El Sahwi S; Kamel M
    Adv Contracept Deliv Syst; 1992; 8(1-2):161-6. PubMed ID: 12285562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of ultrasonography to intrauterine contraception.
    Defoort P; Thiery M
    Contracept Deliv Syst; 1981 Jan; 2(1):1-20. PubMed ID: 12278584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of pelvic inflammatory disease in women using intra-uterine device--a prospective study at the Kenyatta National Hospital.
    Abdulla SH
    J Obstet Gynaecol East Cent Africa; 1982 Dec; 1(4):156-8. PubMed ID: 12313676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive overview of intrauterine contraceptive device (IUCD).
    Nnatu S
    J Obstet Gynaecol East Cent Africa; 1983 Sep; 2(3):91-6. PubMed ID: 12340192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro sperm penetration tests and PCTs in fertile women wearing different medicated IUDs (Cu and progesterone)].
    Bruno V; Dondero F; Moro M; Cerasard M; Carenza L
    Contracept Fertil Sex (Paris); 1986 Feb; 14(2):143-9. PubMed ID: 12267800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of clinic related factors on continuation rates of IUDs.
    Reading AE; Goldstuck ND
    Contracept Deliv Syst; 1982 Jan; 3(1):1-9. PubMed ID: 12264121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statement on intrauterine devices (IUDs).
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1987 Dec; 21(6):3-5. PubMed ID: 12268853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some observations on intrauterine contraceptive device (Lippes loop).
    Menon MK
    J Obstet Gynaecol India; 1970 Jun; 20(3):289-97. PubMed ID: 12275251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.